- Projects & figures
- News & Events
- Managing your project
- About ERC
The increasing development of wearable technology sparks the need for new, innovative ways to interact with our shiny gadgets. Deviating from the conventional approach based on touch-sensitive devices, Prof. Jürgen Steimle aims at producing body-worn user interfaces that can be applied directly on the skin. Highly personalised, biocompatible and ultrathin, these devices will seamlessly blend with the human skin to create a technological extension of our body.
Ole Kamstrup, MD., MSc., is a pensioner and lives north of Copenhagen in Denmark. He has been diagnosed with Parkinson's disease ten years ago. Since 2013, Mr Kamstrup has been in contact with Professor Deniz Kirik, a neuroscientist at Lund University in Sweden. Professor Kirik, who was awarded an ERC Starting Grant in 2009, develops new therapies for Parkinson’s disease, using viral vectors to deliver therapeutic genes to the brain. An ERC Proof of Concept grant enabled him to start carrying out a market evaluation and writing a business plan for the promising therapy.
Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."
While women inherit two X chromosomes, the expressions of one of them is shut down during embryonic development. Men have one X chromosome and one Y chromosome. The switching off of women’s second X chromosome is thought to compensate for the presence of only one X in males versus two in females, to balance for X-linked gene products between the sexes. X-chromosome inactivation is also one of the clearest examples of what epigenetic mechanisms do to our genetic material: the DNA of the genes on the X is still present but not actively expressed or needed. Prof. Edith Heard was awarded ERC grants to understand the intricate processes behind the phenomenon, with unexpected results that changed the way gene regulation is now looked at.
ERC grantee Professor Deniz Kirik's spin-off company will join forces with Skåne Regional Council in southern Sweden to build a specialised hospital and a state-of-the-art gene therapy centre, the parties announced on 8 October. The new facilities are expected to be operational by 2020. They will provide researchers unique opportunities for clinical trials, while patients will gain access to the latest treatment methods for Parkinson’s disease and other illnesses.
It has long been a sci-fi dream to have a humanoid robot in our everyday life. Soon that dream may seem even more vivid, thanks to Dr Pierre-Yves Oudeyer’s ERC-funded project. His team has developed the first complete open-source 3D printed humanoid robot, called “Poppy”. Poppy is a robot that anybody can build – its body is 3D printed and its behaviour programmed by the user. The technology will be of benefit to the fields of science, engineering, education and even the arts.
Compared to humans, the sensing and dexterity of current robots is extremely limited. Reproducing these fundamental human abilities in robotics systems requires a new scientific and technological approach, according to Professor Danica Kragic.
With their transparent skin and a known genome, the zebrafish larvae are emerging as a model for neuroscientists. It enables researchers to monitor large portions of the brain in an intact behaving vertebrate. Dr German Sumbre, an ERC grantee from Argentina, uses zebrafish in order to achieve a better understanding of the neural mechanisms of sensory perception, and as a means of providing new insights into neurological disorders.